Skip to content

Public FDA record

Z-1820-2024: HeartSine samaritan PAD (Public Access Defibrillator), Type: SAM 350P, SAM 360P, SAM 450P

Recall record Z-1820-2024 for HeartSine Technologies Ltd. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1820-2024
Company in FDA record
HeartSine Technologies Ltd
FDA classification date
May 14, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Automated external defibrillators have a manufacturing issue that could prevent the device from delivering instructional voice prompts to the user during use of the device. Visual instructional icons will still be present, but this issue could potentially lead to no therapy or a delay in therapy.

Source facts

Action
On 04/08/24 Stryker sent correction notices to customers informing them of the following: 1) Follow instructions to power cycle affected devices: a) Check the expiration date on the Pad-Pak and if passed, do not use and replace the expired Pad-Pak. b) Place the affected device face up on a flat surface and slide the Pad-Pak into the affected device until you hear the "double click." c) Verify that the green Status indicator is blinking to indicate the initial self-test routine has been performed and the device is ready for use. d) Press On/Off button. c) Listen for, but do not follow, voice prompts. -If you do not hear a prompt, contact your Authorized Distributor or HeartSine Technologies Technical Support at: heartsinesupport@stryker.com -If you hear prompt "Adult patient" and/or "Call for medical assistance", no further action is needed. d) Press On/Off button. If you have not heard a warning message and the status indicator continues to flash green, the device is ready for use. e) Carry out check once every three months and maintain awareness. f) Audio issue will not cause a warning message, but if any other warning messages are played, or you see a red flashing status indicator, please refer to User Manual (General Troubleshooting). 2) Complete/return the response form to RSRecall@stryker.com. 3) If further distributed, email to RSRecall@stryker.com. Stryker will work with you to ensure recipients are notified. 4) If you have any questions or concerns, contact Customer Support at +44 28 9093 9400, 9A.M. to 5P.M. (GMT), or by email at RSRecall@stryker.com. On 3/17/2025, additional correction notices were sent and in addition customers were informed: - Keep track of the total number of impacted devices as well as the number of devices that do not provide audio prompts (if any). - If unable to complete this check every 3 months, please reach out to RSRecall@stryker.com for further alternative solutions that may be applied.
Initiated
2024-04-08
Root cause
Process control
Distribution
US Nationwide distribution including in the states of AK, AL, AR, AS, AZ, CA, CO, CT, DC, DE, FL, GA, GC, HI, IA, ID, IL, IN, KS, KY, LA, MA, MB, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VI, VT, WA, WI, WV, WY.
Recall number
Z-1820-2024
Recall status
Open, Classified
CDRH record ID
206255
FDA classified
2024-05-14
Recall event number
94076

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗